{
  "package" : "hl7.fhir.r4.core@4.0.1",
  "definition" : "Description: \\n                        \\r\\n\\n                        Substitution occurred or is permitted with another product that is a:\\r\\n\\n                        \\n                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester\\n                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration\\n                        \\n                        \\n                           Examples: \\n                        \\r\\n\\n                        \\n                           \\n                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate\\n                           \\n                              Pharmaceutical equivalent: Lisonpril for Zestril",
  "system" : "http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution",
  "property" : [ {
    "_uri" : "http://hl7.org/fhir/concept-properties#child",
    "code" : "child",
    "_implicit" : true,
    "valueCode" : "G"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#child",
    "code" : "child",
    "_implicit" : true,
    "valueCode" : "BC"
  }, {
    "_uri" : "http://hl7.org/fhir/concept-properties#parent",
    "code" : "parent",
    "_implicit" : true,
    "valueCode" : "E"
  } ],
  "codesystem" : "76b07fcd-8e64-5a53-868f-832c45de3671",
  "concept_id" : "7e2ba8d4-d6b3-59cf-808a-0e9bd4e4a662",
  "ancestors" : {
    "E" : 1,
    "EC" : 0,
    "_ActSubstanceAdminSubstitutionCode" : 2
  },
  "id" : "8dc7e54b-3f92-428a-8791-150bdc1f6cce",
  "code" : "EC",
  "display" : "equivalent composition",
  "version" : "2018-08-12"
}